Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Ascelia Pharma AB (publ)
  6. News
  7. Summary
    ACE   SE0010573113

ASCELIA PHARMA AB (PUBL)

(ACE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ASCELIA PHARMA AB (PUBL)
12/01Results from Orviglance comparison study to gadolinium presented at RSNA 2021
AQ
12/01Ascelia Pharma AB Announces Results from Orviglance comparison study to gadolinium pres..
CI
11/30Nomination Committee appointed for AGM 2022 in Ascelia Pharma AB
AQ
11/04QUARTERLY REPORT Q3 2021 : Oncoral – entering clinical collaboration
AQ
11/04Ascelia Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended ..
CI
10/19ASCELIA PHARMA : Food Effect Study with Orviglance successfully completed
AQ
10/19Ascelia Pharma AB Completes Food Effect Study with Orviglance Successfully
CI
09/21ASCELIA PHARMA : Signs Clinical Collaboration Agreement With Taiho Oncology, Inc. for the ..
AQ
09/21Ascelia Pharma Signs Clinical Collaboration Agreement With Taiho Oncology, Inc. for the..
CI
09/20ASCELIA PHARMA AB(OM : ACE) added to S&P Global BMI Index
CI
09/13Certain Ordinary Shares of Ascelia Pharma AB are subject to a Lock-Up Agreement Ending ..
CI
08/19QUARTERLY REPORT Q2 2021 : Preparing Oncoral for the next level
AQ
08/19Ascelia Pharma AB publ Announces Earnings Results for the Second Quarter Ended June 30,..
CI
08/18ASCELIA PHARMA : Covid-19 extends recruitment period of SPARKLE study
AQ
08/18Ascelia Pharma AB Announces That the Continued Global Impact of the Covid-19 Pandemic C..
CI
More most relevant news
All news about ASCELIA PHARMA AB (PUBL)
12/01Results from Orviglance comparison study to gadolinium presented at RSNA 2021
AQ
12/01Ascelia Pharma AB Announces Results from Orviglance comparison study to gadolinium pres..
CI
11/30Nomination Committee appointed for AGM 2022 in Ascelia Pharma AB
AQ
11/04QUARTERLY REPORT Q3 2021 : Oncoral – entering clinical collaboration
AQ
11/04Ascelia Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended ..
CI
10/19ASCELIA PHARMA : Food Effect Study with Orviglance successfully completed
AQ
10/19Ascelia Pharma AB Completes Food Effect Study with Orviglance Successfully
CI
09/21ASCELIA PHARMA : Signs Clinical Collaboration Agreement With Taiho Oncology, Inc. for the ..
AQ
09/21Ascelia Pharma Signs Clinical Collaboration Agreement With Taiho Oncology, Inc. for the..
CI
09/20ASCELIA PHARMA AB(OM : ACE) added to S&P Global BMI Index
CI
More news
News in other languages on ASCELIA PHARMA AB (PUBL)

- No features available -

More news
Press releases
12/01Results from Orviglance comparison study to gadolinium presented at RSNA 2021
AQ
11/30Nomination Committee appointed for AGM 2022 in Ascelia Pharma AB
AQ
11/04QUARTERLY REPORT Q3 2021 : Oncoral – entering clinical collaboration
AQ
10/19ASCELIA PHARMA : Food Effect Study with Orviglance successfully completed
AQ
09/21ASCELIA PHARMA : Signs Clinical Collaboration Agreement With Taiho Oncology, Inc. for the ..
AQ
More press releases
Upcoming event on ASCELIA PHARMA AB (PUBL)
02/10/22